Skip to main content
DRD2 Promoter Region Variation as a Predictor of Sustained Response to Antipsychotic Medication in First-Episode Schizophrenia Patients
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account?
Sign in